Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4398 USD | +9.95% | +1.15% | +42.33% |
May. 15 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
May. 14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.33% | 40.23M | |
+63.54% | 62.59B | |
-1.79% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.59% | 26.21B | |
-21.91% | 19.09B | |
+4.17% | 13.08B | |
+25.61% | 12.26B | |
+28.08% | 12.05B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q4 2019 Earnings Call, Mar 30, 2020